FIND A BIOALPS ACTOR

News

If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Latest BioAlps news

SOPHiA GENETICS Expands it’s Executive Team

A new Chief Marketing Officer and a new Chief Information Officer have joined SOPHiA GENETICS’ Executive Team SOPHiA GENETICS, leader in...

EPFL

EPFL : The path of breast-to-brain cancer metastasis

EPFL scientists have discovered the path used by breast cancer cells to metastasize to the brain   One of the...

Fresenius Kabi

Fresenius Kabi expands biosimilar research activities in Eysins

Fresenius Kabi expands biosimilar research activities – Inauguration of state-of-the-art R&D center in Eysins, Switzerland   On 18 September 2019,...

Virdis Group

Virdis Group furthers Swiss expansion

Virdis Group announces new office opening in Lausanne, Switzerland to further Swiss expansion.

Healthcare Konnect

CureMetrix and HealthCare Konnect join forces

LA JOLLA, California, (Aug 29, 2019) – CureMetrix® a healthcare technology company that develops computer-aided detection (CAD) artificial intelligence (AI)...

University of Fribourg

Fribourg University Launches A New Master of Medicine

A new Master of Medicine was launched this autumn at Fribourg University, designed in collaboration with the Fribourg Hospital (HFR)...

Abionic

Efficiency Proof of Abionic’s Revolutionizing Sepsis Diagnosis Solution

International pivotal study successfully demonstrates Abionic’s diagnosis of sepsis within 5 minutes – 24 hours earlier compared with current standard-of-care...

EPFL

At EPFL AI fosters synergy between man and robot

EPFL scientists are using AI to improve control over robotic hand use for amputees   Artificial Intelligence (AI) is used...

HUG

Artificial Intelligence supporting HUG’s cancer treatment solutions

This year, HUG have implemented Watson for Genomics: the search engine based on tumour genetic information   Watson for Genomics...

Abionic

Abionic Signs Agreement with Genentech

Abionic and Genentech have signed an agreement to develop and provide rapid Point-of-Care tests for Asthma in the US  ...

Swiss-based startup EBAMed raises CHF 1.2 Million

Funding supports development of first integrated heart motion management
system and pre-clinical testing

Drug Delivery

A glass needle gives new hope

A minuscule needle synonymous of hope for 16 million patients   FEMTOprint has developed, in partnership with the EPFL and...

ADC Therapeutics and SOPHiA GENETICS partner for biomarker discovery

ADC Therapeutics and SOPHiA GENETICS Partner in Pivotal Phase II Clinical Trial   Study to identify genomic markers associated with...

HUG

A magical healing sponge

HUG‘s Experimental Cell Therapy Lab has developed a stem cell based magical healing sponge   The bioabsorbable sponge has proven...

CHUV

Professor Solange Peters & team receive the Bonnie J. Addario 2019 prize

CHUV Professor Solange Peters & team were granted this year’s GO2 Foundation prize   This year’s Bonnie J. Addario prize...

pharma

Pharma industry is boosting Swiss exports

Pharma products take first place on the Swiss export board   The high demande from international markets drives Swiss pharma...

Pryv and BGO launch privacy-centric eCRF solution

The innovative RWD eConsent solution is ideal for enhancing clinical trials with Real-World Data (RWD), achieving privacy compliance and improving...

UNIGE HUG

New head of UNIGE’s Faculty of Medicine and HUG’s Teaching and Research Department

Professor Cem Gabay has been appointed as the new Dean of the Faculty of Medicine (UNIGE) and Head of the...

AMAL Therapeutics acquired by Boehringer Ingelheim

Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform   Boehringer Ingelheim announced...

A “smart bra” for detecting breast cancer

Introducing the SBRA “smart bra” project   The SBra project aims to develop an intelligent bra, equipped with sensors, capable...

Sophia Genetics

SOPHiA GENETICS welcomes Troy Cox to its Board of Directors

Troy Cox joins SOPHiA GENETICS as the company expands its decentralized approach to Data-Driven Medicine to foster a sustainable and...

UNIGE – Medicines made of solid gold

Medicines made of solid gold to help the immune system   By studying the effects of gold nanoparticles on the...

UNIGE

UNIGE – Detecting problems of the anti-bleeding system in 60 minutes

UNIGE and Franche-Comté University researchers have co-developped an innovative device enabling platelet capacity detection   This tool investigates a patient’s...

UNIGE

UNIGE : Yves Flückiger appointed as Rector for a second term

The appointment of the new rectorate of UNIGE by the Council of State was revealed on Thursday 20 June 2019.   Prof....

The Wyss Center has a new Director

Dr Mary Tolikas has been appointed as the new Director of the Wyss Center   “The Executive Board of the...

UNIGE and UNIL : “A model to decipher the complexity of gene regulation”

Scientist at the Universities of Geneva and Lausanne, Switzerland, designed a framework to analyse gene regulation, and offer a model...

Asceneuron : New member appointed to the Board of Directors

Asceneuron, an emerging leader in the development of orally bioavailable modulators of tau for the treatment of neurodegenerative diseases, today...

The 2019 Global Startup Ecosystem Report is now available!

The Bern-Lausanne-Geneva region has been ranked #22 worldwide in this year’s edition of the Global Startup Ecosystem Report   Not only...

SICHH

The Swiss Integrative Center for Human Health (SICHH) and the Human Brain Project (HBP) unite

The SICHH and the HBP unite to further research on Alzheimer’s disease and dementia.   The SICHH welcomes the HBP...

Deep Cube – A Success Story

Watch Deep Cube‘s video and learn more about one the canton of Vaud’s striving startups!        

Back to the sources of neural diversity

By deciphering the genetic programmes of neurons of the cerebral cortex, Swiss and Belgian researchers unravel the mechanisms controlling the...

Avatarion will be present at the Digital Heath Connect

Avatarion : Robots in healthcare   The Digital Health Connect will take place on 7 June in Sierre in the...

The startup as an innovative partner

Creating bridges between a large corporation and start-ups is not always an easy task. However, this becomes indispensable to ensure...

A natural barrier which prevents tumors from metastasizing

EPFL scientists have discovered a natural barrier which prevents tumors from forming new tumors or metastasizing.    Scientists from the...

SamanTree Medical

SamanTree Medical raises CHF 9.5 million

SamanTree to start commercializing its Histolog Scanner The Lausanne based startup has raised CHF 9.5 million to help launch the...

BioAlps Networking Day

Save the Date : BioAlps Networking Day 2019

The event will take place on 29 October 2019 @ Théâtre du Crochetan, Monthey (VS).   Our afternoon event will...

MindMaze

MindMaze – “Gamifying rehabilitation for stroke survivors”

Tej Tadi, founder of MindMaze, redefines stroke treatment via virtual reality   The Guardian highlights MindMaze‘s advancement in the field of...

Volumina Medical

Volumina Medical rewarded at the Startup Champions Seed Night

Volumina Medical won the Seed Night prize for its injectable implant.   The event organized by the EPFL, Venturelab and...

Arkathon

Arkathon – Hacking Health Valais

The 5th edition of the Arkathon – Hacking Health Valais took place from 12 to 14 April in Sion.  ...

Sophia Genetics

A new achievement for SOPHiA GENETICS

SOPHiA GENETICS’ Solid Tumor Solution (STS) receives the CE-IVD marking   Western Switzerland based global leader in Data-Driven Medicine, SOPHiA...

EspeRare

EspeRare announces a partnership with Dermelix Biotherapeutics

EspeRare annonce un partenariat avec Dermelix Biotherapeutics pour DMX-101, et le lancement de la phase pivotale pour une thérapie in...

ERC

EPFL professors awarded ERC Advanced Grants

Two EPFL professors received ERC Advanced Grants for their research in cell science and immunotherapy   Professors Pierre Gönczy and...

The Swiss Venture Capital paradigm is shifting

Is Swiss Venture Capital now rising too fast?   A few years back, Swiss pension funds remained cautious when it...

EPFL

EPFL : A new achievement towards personalized medicine

Scientists from EPFL’s BionanoPhotonic Systems (BIOS) Laboratory have created a powerful sensor which will be able to support at-home disease identification.  ...

CHUV

CHUV : Prof Pantaleo’s HIV discovery recognized world wide

Prof Pantaleo’s work published as part of the “Milestones” edition of Nature.   In this edition, Nature identifies the 21...

Tech Tour Award

SOPHiA GENETICS wins the 2019 Tech Tour Growth Award

SOPHiA GENETICS was awarded the 2019 Tech Tour Growth Award out of a pool of 50 companies.   The selecting...

EPFL’S Blue Brain Project breakthrough

The EPFL’s Blue Brain Project has identified how to mathematically determine a neuron type classification based on the neuron’s shape....

An established antibiotic could help treat an aggressive form of breast cancer

UNIGE and UNIL scientists have discovered that clofazimine can be used to reduce tumors in the case of “triple negative” breast...

“Engineering cellular function without living cells”

Imitating the complexity of cellular function while having access to a simpler system which can be mathematically altered.   Scientists...

Aktiia changes the cuffless blood pressure measurement paradigm

Aktiia’s cuffless blood pressure measurement device only needs calibrating every two months   Aktiia’s founders have worked for the past...

Digital Health Hub

Launch of the Digital Health Hub @Biopôle

On 14 March 2019, the Digital Health Hub was launched @Biopôle   The Digital Health Hub was inaugurated today @Biopôle...

Blood Cells

Vitamin B3 analogue increases the efficiency of certain cancer treatments

Intake of Vitamin B3 analogue increases blood cell creation and in-turn positively impacts leukemia and aggressive lymphomas treatments.   Scientists...

MedCo : Medical data safely accessible

The MedCo software, developed by EPFL and CHUV researchers, grants access to medical data from different sources while respecting the...

Using Bioinformatics to Understand Genetic Diseases

The Swiss Bioinformatics Institute (SBI) and the University of Manchester have published a Practical Guide to understand “basic bioinformatics approaches...

Novostia

Neuchatel based Novostia raises CHFF 6.5 million

The funds, raised from private investors, will support Novostia in carrying out the first clinical trials.   Novostia has developed, in...

Innovaud

Scale Up Vaud: 2360 jobs worldwide in 2019

“The Scale Up Vaud initiative continues to grow and welcomes five new members.”   Innovaud shares the outcomes and statistics...

SimplicityBio

Precision for Medicine acquires SimplicityBio

The Valais based startup, SimplicityBio acquired by the USA group Precision for Medicine on 6 March 2019.   Precision for...

EPFL – The bacteria’s gait

“Bacteria walk (a bit) like we do”   Research at the EPFL’s Institute of BioEngineering and Global Health has been...

HUG

HUG breakthrough – Towards a personalized vaccine against brain cancer

The HUG, as part of the GAPVAC (Glioma Actively Personalized Vaccine Consortium) consortium financed by the European Union, have reached a...

Nanolive

Nanolive : T-cells killing cancer cells

Nanolive SA develops a high speed, high resolution and label-free live cell imaging microscope to look instantly inside living cells in...

Lunaphore

Lunaphore’s first product reaches the market

EPFL spin-off, Lunaphore released on 7 February 2019 it’s “rapid screening test for cancer”.   Lunaphore has acquired the CE...

CSEM

CSEM News : First successful osseo-neuromuscular implant

CSEM has contributed to the first dexterous and sentient hand prosthesis implant.   A female Swedish patient with hand amputation has...

Launch of the Swiss stress network

Over 30 scientists from different Swiss universities have joined the newly launched Swiss stress network.   The network enables thorough...

Lonza

Lonza to invest CHF 1 billion over 3 years in its Swiss sites

“Lonza invests 12% of its sales revenue in its plants” in Visp (VS).   Marc Funk will replace Richard Ridinger...

ChemAlive moves to the business stage

Congratulations to ChemAlive, the Lausanne (Vaud) based startup, who has just moved from its R&D to its business phase! “… The...

Alzheimer

Progressive signaling changes in the olfactory nerve of Alzheimer’s disease patients

SICHH contribue à une avancée dans la recherche des symptômes précoces de la maladie d’Alzheimer. L’équipe du Dr Alberi publie...

ADC Therapeutics

ADC Therapeutics launches Phase I clinical trial

The Swiss based startup, ADC Therapeutics, has dosed a solid tumor patient in its first Phase I clinical trial.  ...

EPFL and UNIL discovery : How a mutated gene can lead to different forms of cancer

“EPFL and UNIL scientists have discovered how a mutated gene can affect the three-dimensional interactions of genes in the cell,...

EPFL and ETH scientists have developed smart microrobots

Research from EPFL and ETH Zurich has lead to the development of microrobots capable of changing shape to according to...

Sophia Genetics

Sophia Genetics signs over 850 hospitals to its “data-driven medicine”

Sophia Genetics closes it Series E funding round with a $77 million cash injection. The Swiss biotech is now used...

MindMaze

MindMaze has become the first Swiss unicorn

MindMaze, spin-off of the EPFL, has developed a neurological rehabilitation system called MindMotionPRO. This system supports patients in their recovery from a...

GSK President announces his departure

GlaxoSmithKline‘s President, Philip Hampton,  has announced his departure a month after the British pharmaceutical group unveiled its plan to create...

11 EPFL Startups @ CES19 in Las Vegas

Eleven startups from EPFL were present @ CES19 this January. The event was a chance for them to showcase their...

Chemotherapy-treated tumors fight back

Researchers at EPFL have discovered that chemotherapy-treated mammary tumors create small vesicles that help them reach new organs. Read the...

Bristol-Myers Squibb to Acquire Celgene for About Billion

“The combined company will have nine products with more than billion in annual sales” Read full article in English from...

EPFL startups raised CHF 217 million in 2018

What a year for EPFL startups with a total amount raised of CHF 217 million in 2018! The investment was...

GSK and Pfizer to create a joint venture

GSK and Pfizer are joining forces to become a worldwide non-prescription drug giant.   Read AGEFI’s full article in French

“X chromosome: how genetics becomes egalitarian”

UNIGE researchers have observed how the second X chromosome in women is gradually inactivated cell by cell to avoid identical...

UNIGE

UNIGE researchers develop U-ExM: expansion microscopy

The University of Geneva researchers have developed U-ExM which delicately inflate cells to facilitate an efficient imaging of cellular ultrastructures....

HES-SO launch two personalized medicine national projects

The projects link personalized medicine and AI to offer the most efficient support at different stages of illness. Read full...

Meet Christophe Ramstein, CEO of Myotest

The Valais based startup provides personalized smart coaching software and services for runners to achieve their performance goals confidently, improve...

Using water molecules to unlock neurons’ secrets

EPFL News : “EPFL researchers have developed a method to observe the electrical activity of neurons by analyzing the behavior...

Grifols

Protéine anti-interférence pour la sécurité des transfusions sanguines chez les patients cancéreux

Medion Grifols Diagnostics finaliste du Prix Entreprise 2018/2019 du Canton de Fribourg. “Des nouveaux médicaments contre le cancer affectent les...

Industrialisé avec le soutien technologique du CSEM, SUN bioscience lance sa plateforme Gri3DTM.

Cet outil représente une première et propulse les organoïdes dans une nouvelle La culture in vitro standardisée, rapide et fiable...

Médecins, mais entrepreneurs dans l’âme

“Deux médecins, l’un au CHUV et l’autre aux HUG, développent des applications qui pourraient s’avérer révolutionnaires. Celles-ci transforment les smartphones...

BioAlps Prize 2018

We are very proud to announce the winners of the BioAlps Academy and Industry Prizes 2018. The BioAlps Award aims...

ADC Therapeutics: pemiers patients traités en Phase I/II sur ADC -602 pour le traitement de leucémie

ADC Therapeutics annonce les premiers patients traités dans le cadre de l’essai clinique de Phase I/II sur ADCT-602 dans le...

Blue Brain Project releases first-ever digital 3D brain cell atlas

“Like “going from hand-drawn maps to Google Earth,” the Blue Brain Cell Atlas allows anyone to visualize every region in...

“More than gut feeling”: Microbiota modulation technology scores at HiE 2018

“GNUBiotics (Switzerland) has won the Ingredients category in the Startup Innovation Challenge at HiE 2018 in Frankfurt. The company is...

Genève inaugure un centre de lutte contre le cancer

Le Centre de recherche translationnelle en onco-hématologie (CRTOH) a été inauguré lundi 26 novembre 2018 à Genève. Cette structure, réunissant...

EPFL partners with Standford to advance life science research

“Catalyze4Life, an Innovation Initiative of EPFL has partnered with the similar SPARK program at Stanford University to further advance its...

Caroline Heid à la tête de Microcity

Neode devenu Microcity, nomme Caroline Heid comme Présidente Lire l’interview de la nouvelle présidente

A hydrogel that adheres firmly to cartilage and meniscus

“EPFL researchers have developed a hydrogel – made up of nearly 90% water – that naturally adheres to soft tissue...

UNIGE: “Le tamoxifène peut freiner la myopathie myotubulaire”

“Des chercheurs de l’Université de Genève (UNIGE) ont identifié une molécule appelée tamoxifène, qui peut arrêter la progression de la...

Science is keeping pace with marathoners

“Thanks to sensors attached to their shoes, long-distance runners can harness the power of algorithms to analyze their stride. The...

Immunity connects gut bacteria and aging

“EPFL scientists have discovered how a dysfunction in the immune system can cause an overload of a gut bacterium. The...

AMAL Therapeutics raises 33.2 million dollars

The Geneva-based startup just announced the completion of its Series B financing round, raising in total CHF 33.2 million. Read Venturelab‘s...

BioAlps World Visibitlity Package 2019

A yearly international programme for our affiliated companies to increase their visibility. “BioAlps Bridging the World” are events giving you...

SEED Biosciences joins three talented ventures at StartLab

“Personalized medicine enabler SEED Biosciences will be the 4th start-up to join Biopôle’s StartLab, the first incubator dedicated to life...

Hidden estrogen receptors in the breast epithelium

“EPFL scientists have uncovered that next to estrogen receptor-positive and -negative cells, there are cells with very low amounts of...

Neode SA devient Microcity SA

“​Afin de soutenir la création et le développement d’entreprises innovantes et de fournir des prestations facilitant le transfert de technologie...

Chemiextra ILMAC 2018

Zusammenfassung der Veranstaltung Den ganzen Artikel lesen

1DROP Diagnostics raises 4.25 million dollars

“Investment will support commercialization and development of panels of new diagnostic tests” Read full article

Chercheuse récompensée à l’Uni de Berne

“L’Université de Berne a distingué la médecin Stephanie Ganal-Vonarburg pour ses travaux sur l’influence des microbes intestinaux de la mère...

TWIICE One exoskeleton is a step towards independence

“The new version of the TWIICE walking-assistance system is not only lighter, more comfortable and more powerful, but patients can...

Innosuisse recrute

Innosuisse recherche un/une collaborateur/collaboratrice scientifique (80-100%) pour l’équipe TST Ce poste s’insère dans la tâche passionnante d’aider à mettre en...

Andrea Ablasser wins the 2018 National Latsis Prize

The medical researcher and EPFL professor Andrea Ablasser, who studies how cells defend themselves against viral and bacterial attacks, has...

Biopôle continues expansion with new building construction

Biopôle has signed a partnership agreement with EPIC Suisse for the construction of a new building @ Epalinges. Construction of...

Breakthrough neurotechnology for treating paralysis

Three patients with chronic paraplegia were able to walk over ground thanks to precise electrical stimulation of their spinal cords...

2018 Technology by Bilan

The latest edition of Technology by Bilan magazine is out today! Great articles and insights from our HeatlhValley key players.

Andhra Pradesh MedTech Zone Limited (AMTZ)

AMTZ-The MedTech Capital of India AMTZ is creating an ecosystem for promoting medical device manufacturers, innovators and startups at Visakhapatnam,...

Innosuisse lance son programme d’impulsion “Technologies de fabrication”

Ce programme d’impulsion s’adresse à des consortiums d’entreprises et de laboratoires désireux de développer des projets d’innovation dans les domaines...

EPFL News – The “nerve-on-a-chip”

“EPFL scientists have developed a miniaturized electronic platform for the stimulation and recording of peripheral nerve fibers on a chip.”...

Switzerland Global Enterprise – Technologies Médicales. La Suisse, Terre d’Opportunités

Lire l’article complet sur le site de la Switzerland Global Enterprise. Dans le cadre de la collaboration Franco-Suisse, un déjeuner d’affaires est organisé à...

AGEFI – Endeavour Vision parmi les leaders mondiaux

Le VC genevois se spécialise dans les medtech Lire l’article complet de l’AGEFI paru le 31 août 2018.

Cendres + Métaux affiche une croissance de 8%

La société biennoise, qui à l’origine se spécialise dans le traitement des métaux précieux, augmente sa croissance grâce à la...

Fribourg – Des soutiens financiers accrus en faveur des PME désormais disponibles

Le 1er octobre, la loi révisée sur la promotion économique entre en vigueur, ainsi que son nouveau règlement adopté par...

Le Valais, Pionnier des biotechnologies ?

Lisez le blog de The Ark Foundation et visionner l’émission Eco-Logique de Canal 9 qui met en avant l’exemple du...

Addex renoue avec les bénéfices au 1er semestre

Addex est retourné au premier semestre en territoire positif au niveau du résultat net, inscrivant un bénéfice net de 2,4...

Obseva: résultats prometteurs pour le traitement linzagolix

Final results of ObsEva SA Phase 2b EDELWEISS trial of Linzagolix show sustained efficacy and Bone Mineral Density safety, for...

Alcon arrive à Genève

Alcon quitte Novartis et choisi le canton de Genève pour s’installer avec une équipe de 700 personnes. Article complet en français...

Biotech, Medtech et Pharma, un trio performant

Plusieurs acteurs de la Health Valley analyse les forces de la région de La Côte dans le domaines des sciences...

Lonza investit 400 millions de CHF à Viège (VS)

Lonza poursuit son développement en finançant la création de deux nouveaux sites dans le Canton du Valais. Article complet en français...

Addex Pharma – recoit un financement de 1,2 M£

Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as part of the Tools for Human...

La convergence des technologies: Contributions aux laboratoires du futur

Article BioAlps paru dans le Magazine Chemiextra de septembre 2018, dans le cadre de l’ILMAC Lausanne.  

Alcon, the eye unit of Novartis will move its headquarters to Geneva after spin-off

On 11 September 2018, Alcon announced that it will move its headquarters to Geneva after spin-off from Novartis. Read full...

BioInnovation Day 2018 – Call for Projects

Apply NOW to pitch your Innovative Life Sciences Project Are you a life sciences researcher or scientist-entrepreneur? Do you have...

La thérapie génique d’Haya contre les maladies cardiaques

Deux fois par semaine Bilan propose le portrait d’une start-up suisse pour investir issues de sa sélection 2018. Aujourd’hui, Haya...

Celgene renforce sa présence à Neuchâtel

Le groupe pharmaceutique américain a inauguré mardi une nouvelle usine à Couvet avec 100 emplois à la clé. Article publié...

Cybermedicine

Cybermedicine : Our society must make choices

What is Cybermedicine’s place in today’s society?   Professor Antoine Geissbuhler, Medical-Head of the Department of CyberHealth and Telemedicine and...

Mapping the brain

Computer science teams up with neuroscience in frontier EU research Read the full article about this colossal project

Our immune responses differ due to age, sex and genetics

Age, sex, and specific human genetic variants are the key factors behind differences between immune responses among healthy humans, finds...

Gene Predictis SA et Synlab Suisse SA annoncent un partenariat stratégique

En vue, la commercialisation conjointe d’un test génétique novateur permettant de mesurer le risque de thrombose associé à l’utilisation de...

Pioneering work from HUG and UNIGE for a safe EBOLA virus vaccine

An Ebola signature The team has successfully defined a “formula” capable of predicting the efficacy and safety of new Ebola...

Un « cocktail » permet aux fibres nerveuses sectionnées de repousser

Des scientifiques ont élaboré une recette en trois étapes qui permet de régénérer chez le rongeur des fibres nerveuses médullaires...

Connaissez-vous vos microbiotes?

Dans un contexte de recherche scientifique mondiale jugée exponentielle, les experts des Hôpitaux universitaires de Genève (HUG) et de l’Université...

“C’est la révolution que l’on attendait contre le cancer”

Lisez l’article de Fabrice Delaye publié dans Bilan Magazine “Alors que le CHUV inaugurera bientôt un centre de recherche dédié, le professeur...

Joint the CES 2019 Las Vegas – January 8-11, 2019 – Swiss Pavilion

Information and Registration CES 2019  January 8-11, 2019

Joint the “Data & Electronics Business Mission”, Silicon Valley / CES 2019 Januray 6-12, 2019

Information and Registration on Data & Electronics Business Mission USA January 6-12, 2019

Apidel SA annonce une levée de fonds auprès d’investisseurs privés

Apidel SA annonce aujourd’hui sa troisième levée importante de fonds auprès d’investisseurs privés. Celle-ci va notamment permettre à l’entreprise de...

Interview du nouveau Président de BioAlps par l’Agefi

Philippe D. Monnier a parlé avec Claude Clément, nouveau Président de BioAlps, de son nouveau rôle et sa vision pour...

InnoSuisse answers your questions

You wish to know more about the funding of innovation projects? You are interested in making a project proposal? Or...

Un traumatisme cérébral détecté en dix minutes

Une goutte de sang suffit à un boîtier mis au point par des chercheurs genevois et espagnols pour diagnostiquer rapidement...

GENOME JUMPER

Un jeu mobile pour explorer la diversité humaine. Comment se fait-il que certaines personnes n’aient pas d’empreintes digitales? Ou que...

Pryv partners with Net4all to launch a managed hosting solution for privacy and personal data manage

This partnership will ensure that sensitive personal data is duly managed thru its lifecycle and kept completely secure under the...

Agefi – Nouvelle présidence chez BiopAlps

Claude Clément reprend la présidence de BioAlps, l’association des sciences de la vie de Suisse occidentale. Lien à l’article de l’Agefi

IAVI, Selexis SA and Collabotators publish a new study

Paper in Frontiers in Immunology Describes Trimer Design and Development of Production CHO Cell Lines That Generate Properly Folded HIV-1...

Recherche de partenariat – Détection Cancer du sein

Recherche d’une entreprise pour un projet dans la détection du cancer du sein Dans le cadre du projet franco-suisse “SBra”...

Kinntek chooses Pryv

Kinntek, announces that it has chosen Pryv to extend its breakthrough hand rehabilitation interactive platform with advanced privacy-preserving capacity. Read...

Oculis raises CHF20 million and moves to Switzerland

Oculis, a clinical-stage biotechnology company focused on the development of non-invasive topical treatment for back-of-the-eye diseases, announced it has successfully...

14ème édition du Prix à l’innovation du canton de Fribourg

Fribourg recherche les entreprises et les start-up les plus innovantes Toutes les entreprises établies dans le canton de Fribourg peuvent...

Swiss BioInformatics Institute celebrates its 20th anniversary

BIOINFORMATICS, A SWISS PRIDE – 20 YEARS OF SERVICE TO THE LIFE SCIENCES AND HEALTH As a pioneer in the...

EspeRare gains rights to relaunch late stage development for a rare genetic disease

EspeRare is delighted to announce that it has concluded an important agreement with Edimer Pharmaceuticals. Lire le communiqué de presse...

Retraites Populaires and Biopôle SA launch the first life sciences incubator in Canton of Vaud

9,100 m2 building, funded and constructed by Retraites Populaires on the site of Biopôle, a leading Swiss life science park....

BioFoundry – Open Insulin Project – Call for Partnering Proposals

The Open Insulin mouvement was started in California with the intention of bringing the price of insulin down. The project’s...

SimplicityBio – Sales Manager position now open

The Swiss based company, founded in 2015, active in the discovery of novel medical biomarkers by means of patented bioinformatics...

Anergis and Mymetics Start Research Collaboration Project

Mymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines, and Anergis SA, a company...

Gene Predictis – Tests génétiques pour prévenir les risques liés aux effets adverse

Des tests pour réduire les risques d’effets nocifs liés aux médicaments et à la nutrition. Un article de l’AGEFI La...

Selexis SA hires new strategic partners to strengthen its cell line development services

Selexis SA announced on 11 April that “it has made key strategic hires, signed its one hundredth commercial license agreement (CLA)...

Ferring acquires Rebiotix Inc.

Ferring announces their acquisition of Rebiotix Inc., microbiome pioneer. “This acquisition brings together two innovative healthcare companies that share a...

ADDEX THERAPEUTICS Sucessfully Raises CHF40 million in Capital Increase

“This is a transformational event for Addex which will enable us to advance our portfolio of allosteric modulator drug candidates...

Le Biopôle recrute un/une “Marketing & Communication Manager – 80% “

La personne sélectionnée sera en charge de la stratégie et les actions marcom du Biopôle Plus d’informations

MEDTRONIC – Open Innovation Days

Presentation of some of the company’s most advanced manufacturing facilities at Tolochenaz on 3 May 2018 Medtronic is among the...

Genomic Health: New Real-World Clinical Practice Data

Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer...

MassChallenge 2018 Accelerator Program

Applications are open until 28 March 2018! Calling all startups! Applications for the MassChallenge 2018 Accelerator Program are open until March...

Discover regenHU’s 3DDiscovery Evolution bio-printer

regenHU will launch their new product @ the IDTechEX Show on 11-12 April 2018 in Berlin, Germany.   regenHU’s 3DDiscoveryTM...

Lunaphore

Lunaphore collaborates with PerkinElmer

The Swiss start-up announced on 20 March that it will collaborate with the American multinational corporation to develop staining and...

La 2ème édition d’Orthomanufacture

Fort du succès enregistré à St Etienne en juin dernier, Orthomanufacture récidive à Yverdon-les-Bains les 20 et 21 juin 2018....

Lundbeck to acquire Prexton Therapeutics

This acquisition will add foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson’s...

Le Challenge Debiopharm Inartis

La qualité de vie du patient en cours de traitement “Qui pourra changer le monde dans lequel nous vivons?” «Construisons...

Luc Stoppini raconte son Prix BioAlps

Prix BioAlps 2017 : la récompense d’une carrière Article du magazine HEPIA news – Mars 2018

Glenmark Pharmaceuticals S.A. to invest in new Translational Research Group @ Biopôle

Glenmark Pharmaceuticals announces it will enhance its capabilities in translational research by opening a new discovery centre at the Biopôle...

Kick-off Medtech Accelerator at EPFL Innovation Park

Monday 12 March @ 17:30, at room Neptune, Building C of EPFL Innovation Park Learn more about La Forge’s new...

Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of An

Selexis SA announces that Compugen Ltd. has taken a license to the Selexis SUREtechnology Platform™ for use in generating high-performance...

Selexis SA and Xencor sign 4 Commercial License Agreements

On 26 February, Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody...

UNIBE – Des cultures cellulaires en 3D contre les résistances des cancers

La médecine de précision, c’est-à-dire la mise au point de traitements personnalisés, est un objectif majeur de la recherche moderne...

Business offer from a German company represented by the Enterprise Europe Network

A German company, part of the Enterprise Europe Network, specialized in planning and interior fitting of hospitals and veterinary clinics...

Ferring: 30 million CHF investment in new biotech centre in Switzerland

Ferring expands its capabilities in biologics through a new biotech centre, which will be installed at its global headquarters and...

Fondation BINC-Geneva – Appels à candidatures

Appels à candidatures pour des financements de recherche (académiques) dans les domaines du microbiote, allergie, obésité infantile et dépression postpartum....

Bilan – Les start-up suisses lèvent un milliard en 2017

600 millions de francs d’investissements en 2017 pour les start-ups Medtech et Biotech en Suisse Lire l’article complet sur la...

Quatre plateformes promeuvent l’innovation en Suisse occidentale

Le Journal Entreprise romande nous dévoile les coulisses des quatres plateformes sectorielles de Suisse occidentale L’article complet est disponible ici.

Launch of The Innovation Finder, a free platform for the innovation actors in Switzerland

The Innovation Finder’s scope is to highlight innovative companies and institutions in the region. The platform contains valuable and complete...

Comment la «Health Valley» séduit les start-ups

«Ici, il y a une vraie convergence entre les technologies informatiques et le domaine médical, créant un environnement très dynamique...

Quartz Bio becomes part of Precision Medicine Group

US-based Precision for Medicine, part of Precision Medicine Group, today announced it is expanding its biomarker data management and translational...

CSEM News

SENSOR-ENHANCED SURGICAL ROBOT ENABLES HIGHLY PRECISE AND SAFE SPINAL OPERATIONS Researchers from the University of Bern, Inselspital, Bern University Hospital...

Bilan – Les Métiers de Demain

Le magazine référence nous informe des nouvelles formations et de leur impact sur l’avenir des métiers de la santé en...

Biopôle recrute un/e Responsable de Laboratoire

Crée par le canton de Vaud (2004), Biopôle est un parc scientifique et une communauté dynamique qui regroupe campus de...

BIOPOLE appoints STARTLAB Advisory Board members & announces first company selected

Appointments made to StartLab Advisory Board 1st candidate: HaYa Therapeutics & GNUbiotics, selected for dedicated life sciences incubator Plug &...

UNRAVELLING THE SECRETS OF THE BRAIN

Bilan and BioAlps special webdoc edition How Western Switzerland’s neurosciences cluster is turning research into innovation. Within a decade, Western...

BioAlps Bridging the World : Worldwide Visibility Package 2018

A yearly international programme for our affiliated companies to increase their visibility A yearly international programme for our affiliated companies...

Incyte est sur le point d’implanter une usine de production à Y-PARC

Incyte est sur le point d’implanter une usine de production à Y-PARC et d’offrir de nouvelles opportunités d’emploi et de...

Nov 1st, OM PHARMA CÉLÈBRE 80 ANS D’EXCELLENCE

80 ANS D’EXCELLENCE BIOPHARMACEUTIQUE À GENÈVE – DE LA BACTÉRIE AU COMPRIMÉ OM Pharma Press Release OM Pharma in the...

ADC Therapeutics raises 200 Million $ Private Financing

ADC Therapeutics Announces Closing of 200 Million $ Private Financing to Fund Two Lead Programs more info

Meet the young graduates in engineering from the University of Applied Sciences

The next forum for the graduates from HES-SO will take place on March 7th, 2018 in the convention center in...

Nouvelle Application – Journal de la recherche HEIA-FR

Mesdames, Messieurs, Nous avons le plaisir de vous informer que le journal de la recherche de la HEIA-FR est désormais...

Le Réseau romand d’oncologie réunissent les compétences d’expert

Initié par le CHUV et les HUG, avec le soutien des fondations Philanthropia et Famsa,le Réseau romand d’oncologie met à...

NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services in the United States, announced today that it has opened...

Prix Perl 2018

Les PERL sont devenus au fil des ans un élément central du soutien de Lausanne Région aux entreprises établies sur...

Pryv SA closes 1.1M CHF Pre-Series A to accelerate growth and prepare Series A funding round

Pryv SA, an independent Swiss Health-IT company, specialized in providing innovative data management and digital privacy solutions, is proud to...

Swiss-German Cooperation Days Biotechnologies 2017

Schlieren, 27.9.2017: Symposium Biotechnologies with Networking Event On behalf of the German Federal Ministry of Economic Affairs and in cooperation...

Swiss-German Cooperation Days Biotechnologies (25.-29.9.2017)

27.9.: Symposium „Laboratory 4.0 and new solutions for efficient processes in biotechnology“ 26.-28.9.: Cooperation talks with potential partners from Germany...

new funding opportunity for ‘Young Researchers’ Exchange Programme’ between Switzerland and Korea

20 fellowships PhD students and young postdocs from Swiss and Korean Universities and Research Institutes a new funding opportunity for ‘Young...

Anergis Announces Results of the ATIBAR Trial

Anergis, a company developing proprietary ultra-fast allergy immunotherapy, announced today the top-line results from the ATIBAR trial, a Phase IIb...

Welcome To Health Valley

Building on skills honed over the centuries, western Switzerland has become a world leader in biotech.    

Vous recherchez un·e stagiaire ou collaborateur ?

Vous avez besoin d’un stagiaire pour avancer dans un projet ? Vous souhaitez recruter un·e diplômé·e ? L’Université de Lausanne...

APPLY NOW : StartLab, the brand new incubator dedicated purely to life sciences

APPLY NOW : StartLab, the brand new incubator dedicated purely to life sciences. The perfect environment for aspiring entrepreneurs to...

Biopôle announces StartLab, tailor-made Incubator for Life Sciences Entrepreneurs

Biopôle SA, a leading Swiss life sciences park, today announced the creation of StartLab, the first incubator dedicated to life...

Merck KGaA, Darmstadt, Germany Licenses Selexis SUREtechnology Platform for Immuno-Oncology Antibody

Geneva, Switzerland, 30 MAY 2017 – Selexis SA, a pioneering life sciences company and a global leader in mammalian cell...

Apidel SA announces R&D collaboration with DNDi in the field of neglected diseases

Apidel announces the signature of an agreement to collaborate with DNDi on the preclinical development of a topical treatment for...

Selexis SA and OSE Immunotherapeutics Sign Commercial License Agreement to Further Advance Developme

Selexis SA and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announced today the signing of a commercial license agreement that...

Séance d’information du CAS/DAS/MAS en droit de la santé

Cette soirée d’information présente la formation continue en droit de la santé de l’Université de Neuchâtel, organisée en collaboration avec...

swissnex India’s Medtech Road Show in Switzerland

Want to be part of the Indian 10 billion CHF Medtech market? Meet swissnex India’s experts from June 12th to...

Health Valley and Swiss Franc

Medtech and biotech resisting Switzerland’s strong currency The life sciences sector continues to grow – and draw in investment and...

Valtronic célèbre son 35e anniversaire

Valtronic, innovateur et fabriquant de produits électroniques miniaturisés et de haute précision pour l’industrie des dispositifs médicaux, célèbre son 35e...

Lonza et Sanofi investissent 290 millions en Valais et créent 200 emplois

Les groupes pharmaceutiques bâlois et français vont construire une usine commune à Viège pour produire des médicaments biologiques Le fabricant...

Prexton Therapeutics lève 29 millions d’euros

Prexton Therapeutics lève 29 millions d’euros dans un second tour pour financer son traitement innovant dans la maladie de Parkinson...

Life Science to Turkey

Switzerland Global Enterprise is organizing a fact finding mission to Turkey for Swiss companies who would like to know more...

CAS Droit pharmaceutique et des biotechnologies

Derniers jours pour s’inscrire Le prochain volet de la formation continue en droit de la santé de l’Université de Neuchâtel...

Etude Lutathera à l’honneur dans le New England Journal of Medicine sur les patients atteints de TNE

AAA, société pharmaceutique installée dans l’arc lémanique et possédant des bureaux à Genève, annonce la publication de ses résultats de...

Medistri 2017 Expansion project

Started in 2006, Medistri is starting the building extension. The company, expert in Sterilisation and Lab testing for med devices,...